4.7 Review

Immunomicelles for advancing personalized therapy

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 64, 期 13, 页码 1436-1446

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2012.08.003

关键词

Personalized therapy; Targeted deliver; Polymeric micelles; Antibody-targeted; Immunomicelles; Imaging; Cancer; siRNA; Atherosclerotic plaques

向作者/读者索取更多资源

Personalized medicine, which ultimately seeks to afford tailored therapeutic regimens for individual patients, is quickly emerging as a new paradigm in the diagnosis and treatment of diseases. The idea of casting aside generic treatments in favor of patient-centric therapies has become feasible owing to advances in nanotechnology and drug delivery coupled with an enhanced knowledge of genomics and an understanding of disease at the molecular level. This review highlights polymeric immunomicelles as a class of nanocarriers that have the potential to combine diagnosis, targeted drug therapy, as well as imaging and monitoring of therapeutic response, to render a personalized approach to the management of disease. Smart multi-functional immunomicelles, as the next generation of nanocarriers, are poised for facilitating personalized cancer treatment. This review provides an assessment of immunomicelles as tools for advancing personalized therapy of diseases, with cancer being the major focus. (C) 2012 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据